Eton to Acquire Increlex® (mecasermin injection) from Ipsen

 Aligns with Eton's Mission to Develop and Distribute Medicines that Have a Life Changing Impact for Patients with Ultra-rare Conditions

Acquisition to Bolster Eton’s Commercial Pediatric Endocrinology Portfolio

https://www.globenewswire.com/news-release/2024/10/03/2957549/0/en/Eton-Pharmaceuticals-Inc-to-Acquire-Increlex-mecasermin-injection-from-Ipsen.html